Serum Institute of India Pvt Ltd.
- Country
- 🇮🇳India
- Ownership
- Subsidiary
- Established
- 1996-01-01
- Employees
- 1K
- Market Cap
- -
Safety Study of Dengushield in Healthy Adults
- Conditions
- DenguePhase 1
- Interventions
- Biological: Dengushield 7 mg/kg (Cohort 3) intravenousBiological: Placebo 7 mg/kg (Cohort 3) intravenousBiological: Placebo 12 mg/kg (Cohort 4) intravenousBiological: Dengushield 1 mg/kg (Cohort 1) intravenousBiological: Dengushield 3 mg/kg (Cohort 2) intravenousBiological: Placebo 3 mg/kg (Cohort 2) intravenousBiological: Dengushield 12 mg/kg (Cohort 4) intravenous
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2020-02-18
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT03883620
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
- Conditions
- Rotavirus Gastroenteritis
- Interventions
- Biological: Liquid Rotavirus Vaccine
- First Posted Date
- 2018-03-22
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 1500
- Registration Number
- NCT03474055
- Locations
- 🇮🇳
Centre for Vaccine Studies, Prasanna School of Public Health, Manipal University, Manipal,, Udupi, Karnataka, India
🇮🇳Hakeem Abdul Hameed Centenary Hospital, New Delhi, Delhi, India
🇮🇳Sri Ramachandra Medical Centre, Chennai, Chennai, Tamil Nadu, India
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds
- Conditions
- Meningitis, Meningococcal
- Interventions
- Biological: Adjuvanted study formulation NmCV-5Biological: Non-adjuvanted study formulation NmCV-5Biological: Menactra
- First Posted Date
- 2017-09-27
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 375
- Registration Number
- NCT03295318
- Locations
- 🇲🇱
Centre pour le Développement des Vaccins du Mali, ex-Institut Marchoux, Ministry of Health, BP251, Bamako, Mali
Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence
- Conditions
- Prevention of TB Recurrence
- Interventions
- Biological: VPM1002 (Recombinant BCG Vaccine)Other: Placebo
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 2000
- Registration Number
- NCT03152903
- Locations
- 🇧🇩
International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh
🇮🇳Mahavir Hospital & Research Centre, Hyderabad, Hyderabad, Andhra Pradesh, India
🇮🇳Government Medical College, Jammu, Jammu, Jammu and Kashmir, India
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization
- Conditions
- Rotavirus Gastroenteritis
- Interventions
- Biological: BRV-PV Lot A + DPT-HepB-Hib + OPVBiological: BRV-PV Lot B + DPT-HepB-Hib + OPVBiological: BRV-PV Lot C + DPT-HepB-Hib + OPVBiological: ROTARIX + DPT-HepB-Hib + OPV
- First Posted Date
- 2015-10-23
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 1500
- Registration Number
- NCT02584816
- Locations
- 🇮🇳
King George Hospital, Visakhapatnam, Andhra Pradesh, India
🇮🇳Bharati Vidyapeeth Medical College and Hospital, Pune, Maharashtra, India
🇮🇳Institute of Child Health, Kolkata, West Bengal, India
Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants
- Conditions
- Immune Response to DTP-HB-Hib Vaccine
- Interventions
- Biological: DTP-HB-Hib vaccineDevice: Disposable Syringe Jet Injector (DSJI)Other: Needle & Syringe
- First Posted Date
- 2015-04-06
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 211
- Registration Number
- NCT02409095
- Locations
- 🇮🇳
Dept of Pediatrics, Sri Ramachandra Medical Centre, No. 1, Ramachandra nagar, Porur,, Chennai, Tamil Nadu, India
🇮🇳Department of Pediatrics, Bharati Vidyapeeth Deemed University Medical College and Hospital, Satara Road, Katraj, Dhankawadi, Pune, Maharasthra, India
🇮🇳Department of Pediatrics, KEM Hospital Research Centre, Sardar Moodliar Road, Rasta Peth,, Pune, Maharashtr, India
Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa
- Conditions
- Tuberculosis
- Interventions
- Biological: VPM1002(Hyg+)Biological: BCGBiological: VPM1002
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 416
- Registration Number
- NCT02391415
- Locations
- 🇿🇦
Children's Infectious Diseases Clinical Research Unit, Tygerberg Hospital, Cape Town, South Africa
🇿🇦Desmond Tutu TB Centre, Cape Town, South Africa
🇿🇦South African Tuberculosis Vaccine Initiative, Cape Town, South Africa
Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children
- Conditions
- Immune Response to MMR Vaccine
- Interventions
- Biological: MMR vaccine
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 341
- Registration Number
- NCT02253407
- Locations
- 🇮🇳
Department of Pediatrics, Bharati Vidyapeeth Deemed University Medical College and Hospital, Satara Road, Katraj, Dhankawadi, Pune, Maharasthra, India
🇮🇳Dept of Pediatrics, Sri Ramachandra Medical Centre, No. 1, Ramachandra nagar, Porur,, Chennai, Tamil Nadu, India
🇮🇳Department of Pediatrics, KEM Hospital Research Centre, Sardar Moodliar Road, Rasta Peth,, Pune, Maharashtr, India
A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
- Conditions
- Rotavirus Gastroenteritis
- Interventions
- Other: PlaceboBiological: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV)
- First Posted Date
- 2014-05-08
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 7500
- Registration Number
- NCT02133690
- Locations
- 🇮🇳
National Institute of Cholera & Enteric Diseases, Kolkata, West Bengal, India
🇮🇳Dr. Sushila Nayar School of Public Health ,Mahatma Ghandi School of Medicine, Sewagram, Maharashtra, India
🇮🇳Dr Dinesh Kumar Government Medical College, Jammu Department of Community Medicine, Government Medical College, Jammu, Jammu & Kashmir, India
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
- Conditions
- Prophylaxis for the Measles Infection
- Interventions
- Biological: PMV via Puffhaler® deviceBiological: Licensed Subcutaneous Measles VaccineBiological: PMV via SoloventTM device
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Serum Institute of India Pvt. Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT01557699
- Locations
- 🇮🇳
Department of Pediatrics, Padmashree Dr. D. Y. Patil Medical College, Pune, Maharashtra, India